2002
- Harris AD, Smith D, Johnson JA, Bradham DD, & Roghmann MC. Risk factors for imipenem-resistant Pseudomonas aeruginosa among hospitalized patients. Clinical Infectious Diseases 34(3):340–345.
- Smith DL, Harris AD, Johnson JA, Silbergeld EK, & Morris JG. Animal antibiotic use has an early but important impact on the emergence of antibiotic resistance in human commensal bacteria. Proceedings of the National Academy of Sciences, USA 99(9):6434–6439. [HTML, PDF, GooSchol, Commentary]
2003
- Smith DL, Johnson JA, Harris AD, Furuno JP, Perencevich EN, & Morris JG. Assessing risks for a pre-emergent pathogen: virginiamycin use and the emergence of streptogramin resistance in Enterococcus faecium. The Lancet, Infectious Disease 3(4):241–249.
- Smith DL & Johnson JA. Antibiotic use in animals and the emergence of antibiotic resistance in human commensal bacteria and zoonotic pathogens. In OIE International Standards on Antimicrobial Resistance, World Health Organization for Animal Health, 12 Rue de Prony, 75017 Paris, France.
2004
- Kelly LA, Smith DL, Snary EL, Johnson JA, Harris AD, Wooldridge M, & Morris JG. Animal growth promoters: to ban or not to ban? A risk assessment approach. International Journal of Antimicrobial Agents 24(3):205–212.
- Perencevich EN, Fisman DN, Lipsitch M, Harris AD, Morris JG, & Smith DL. Projected benefits of active surveillance for vancomycin resistant enterococcus in intensive care units. Clinical Infectious Diseases 38(8):1108–1115.
- Harris AD, Nemoy L, Johnson JA, Martin-Carnahan A, Smith DL, Standiford H, & Perencevich EN. Co-carriage rates of vancomycin-resistant Enterococcus and extended-spectrum β-Lactamase-producing bacteria among a cohort of intensive care unit patients: Implications for an active surveillance program. Infection Control & Hospital Epidemiology 25(2):105–108.
- Smith DL, Dushoff J, Perencevich EN, Harris AD, & Levin SA. Persistent colonization and the spread of antibiotic resistance in nosocomial pathogens: resistance is a regional problem. Proceedings of the National Academy of Sciences, USA 101(10):3709–3714.
2005
- Smith DL, Dushoff J, Morris JG. Agricultural antibiotics and human health: Does antibiotic use in agriculture have a greater impact than hospital use? PLoS Medicine2(8):e23.
- Smith DL, Levin SA, Laxminarayan R. Strategic interactions in multi-institutional epidemics of antibiotic resistance. Proceedings of the National Academy of Sciences, USA 103(8):3153–3158.
- Laxminarayan R, Smith DL, Real LA, Levin SA (2005). On the importance of incentives in hospital infection control spending. Discovery Medicine 5(27):303–308.
2006
- Furuno JP, McGregor JS, Harris AD, Johnson JA, Johnson JK, Langenberg P, Venezia RA, Finkelstein J, Smith DL, Strauss SM, Perencevich EN. Identifying high risk groups for carriage of antibiotic-resistant bacteria. Archives of Internal Medicine 166:580–585.
- Laxminarayan R, Over M, Smith DL. Will a global subsidy of antimalarials delay the emergence of resistance and save lives? Health Affairs 25(2):325–336.
- Hartley DM, Furuno JP, Wright MO, Smith DL, Perencevich EN. The role of institutional epidemiologic weight in guiding infection surveillance and control in community and hospital populations. Infection Control and Hospital Epidemiology 27(2):170–174.
- Smith DL, Boni MF, Laxminarayan R. Dynamics and control of antibiotic resistance in structured metapopulations. Chapter 11 in Feng Z, Dieckmann U, Levin S, eds. Disease evolution: Models, concepts, and data analyses, 213–237. DIMACS Series in Discrete Mathematics and Theoretical Computer Science. American Mathematical Society.
- Laxminarayan R, Smith DL. Ecology and economics of cycling antibiotics: Insights from mathematical modeling. Chapter 8 in CF Am ́abile-Cuevas ed. Antimicrobial Resistance in Bacteria, pp 169-180. Taylor & Francis, Inc.
2007
- Klein E, Smith DL, Laxminarayan R. Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005. Emerging Infectious Diseases 13(12):1840–1846.
- Laxminarayan R, Malani A, Howard D, Smith DL. Extending the Cure. Resources for the Future, Washington, DC.
- Smith DL. The epidemiology of antibiotic resistance: Policy levers. Chapter 2 in Extending the Cure. Robert Woods Johnson Foundation.
2008
- Boni MF, Smith DL, Laxminarayan R. Benefits of using multiple first-line therapies against malaria. Proceedings of the National Academy of Sciences, USA105(37):14216-21.
- Klein EY, Smith DL, Boni MF, Laxminarayan R. Clinically immune hosts as a refuge for drug-sensitive malaria parasites. Malaria Journal 7:67.
- Smith DL, Laxminarayan R. Human interventions on the evolution of host-bacteria interactions. Chapter 6 in Baquero F and JAG Fuentes, eds. Evolutionary Biology of Bacterial and Fungal Pathogens, pp 51-62. ASM Press, Washington, DC.
2009
- Escalante AA, Smith DL, Kim Y. The dynamic of mutations associated with antimalarial drug resistance in Plasmodium falciparum. Trends in Parasitology 25(12):557-563.
- Klein E, Smith DL, Laxminarayan, R. Community-associated methicillin-resistant Staphylococcus aureus in outpatients, United States, 1999-2006. Emerging Infectious Diseases 15(12):1925-1930.56.
2012
- Klein EY, Smith DL, Laxminarayan R, Levin SA. Superinfection and the evolution of resistance to antimalarial drugs. Proceedings of the Royal Society of London B Biolological Sciences 279(1743):3834-42.
- Geli P, Laxminaryan R, Dunne M, Smith DL. “One-size-fits-all?” Optimizing treatment duration for bacterial infections. PLoS One 7(1): e29838.
- Eisenberg JNS, Cevallos W, Trueba G, Levy K, Scott J, Percha B, Segovia R, Ponce K, Hubbard A, Foxman B, Smith DL, Trostle J. In-roads to the spread of antibiotic resistance: Regional patterns of microbial transmission in northern coastal Ecuador. Journal of the Royal Society Interface 9:1039-39.
2013
- Klein EY, Sun L, Smith DL, Laxminarayan R. The changing epidemiology of methicillin-resistant Staphylococcus aureus in the United States: A national observational study. The American Journal of Epidemiology 177:666-674.
2014
- Kouyos RD, Metcalf CJE, Birger R, Klein EY, zur Wiesch PA, Ankomah P, Arinaminpathy N, Bogich TL, Bonhoeffer S, Brower C, Chi-Johnston G, Cohen T, Day T, Greenhouse B, Juijben S, Metlay J, Mideo N, Pollitt LC, Read AF, Smith DL, Wale N, Grenfell B. The path of least resistance: aggressive or moderate treatment? Proceedings of the Royal Society of London, B, Biological Sciences 281: 20140566. [Web]